Reasons to switch: a noninterventional study evaluating immunotherapy switches in a large German multicentre cohort of patients with relapsing-remitting multiple sclerosis

Background: With a large array of disease modifying therapies (DMTs) for relapsing-remitting MS (RRMS), identifying the optimal treatment option for the individual patient is challenging and switching of immunotherapies is often required. The objective of this study was to systematically investigate...

Ful tanımlama

Detaylı Bibliyografya

Asıl Yazarlar:	Mathias Mäurer, Klaus Tiel-Wilck, Eckard Oehm, Nils Richter, Michael Springer, Patrick Oschmann, Arndt Manzel, Stefanie Hieke-Schulz, Vera Zingler, Julia A. Kandenwein, Tjalf Ziemssen, Ralf A. Linker
Materyal Türü:	Artigo
Dil:	Inglês
Baskı/Yayın Bilgisi:	SAGE Publishing 2019-12-01
Seri Bilgileri:	Therapeutic Advances in Neurological Disorders
Online Erişim:	https://doi.org/10.1177/1756286419892077
Etiketler:	Etiketle Etiket eklenmemiş, İlk siz ekleyin!